TMEM125: A Potential Drug Target for Cancer (G128218)

Target Name: TMEM125

NCBI ID: G128218

TMEM125

TMEM125: A Potential Drug Target for Cancer

TMEM125 (Tumor Membrane Extrusion Model 125) is a protein that is expressed in various tissues of the body, including the skin, hair, and nails. It is also a well-established biomarker for cancer, and has been shown to be associated with the development and progression of several types of cancer.

TMEM125 is a transmembrane protein that is involved in the regulation of cell signaling pathways. It is a member of the tumor membraneextrusion (TMEM) family, which includes several other proteins that are involved in the process of cell signaling. TMEM125 is expressed in a variety of tissues, including the skin, hair, and nails, and has been shown to be involved in the development and progression of several types of cancer.

One of the key functions of TMEM125 is its role in cell signaling pathways. It is a negative regulator of the TGF-β pathway, which is a well-established pathway that is involved in the regulation of cell growth, differentiation, and survival. TGF-β is a cytoplasmic protein that is involved in the regulation of cell signaling pathways, and it is thought to play a role in the development and progression of cancer. TMEM125 is shown to interact with TGF-β and to inhibit its activity, which suggests that it may be a potential drug target for cancer.

In addition to its role in cell signaling pathways, TMEM125 is also involved in the regulation of cell adhesion. It is a member of the cadherin family of transmembrane proteins, which are involved in cell adhesion and the formation of tight junctions. TMEM125 is shown to be involved in the regulation of cadherin function, which suggests that it may be a potential biomarker for cancer.

TMEM125 is also involved in the regulation of cell migration. It is a member of the vimentin family of cytoskeletal proteins, which are involved in the regulation of cell migration. TMEM125 is shown to be involved in the regulation of vimentin function, which suggests that it may be a potential drug target for cancer.

In conclusion, TMEM125 is a transmembrane protein that is involved in the regulation of cell signaling pathways, cell adhesion, and cell migration. It is also a well-established biomarker for cancer and has been shown to be associated with the development and progression of several types of cancer. As such, TMEM125 may be a potential drug target for cancer. Further research is needed to determine the exact mechanisms of TMEM125's role in cancer and to develop effective treatments.

Protein Name: Transmembrane Protein 125

The "TMEM125 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM125 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets